The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - In8bio
Consulting or Advisory Role - in8bio
Phase 1 trial of drug resistant immunotherapy: A first-in-class combination of MGMT-modified γδ t cells and temozolomide chemotherapy in newly diagnosed glioblastoma.
 
Louis B. Nabors
Consulting or Advisory Role - BTG; Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Development of novel inhibitors to HuR through NCI funded peer reviewed research.
Other Relationship - University of Pennsylvania; ZIOPHARM Oncology
 
Lawrence S. Lamb
Employment - In8bio
Leadership - In Compass Health
Stock and Other Ownership Interests - In8bio
 
Melissa Jo Beelen
Employment - Epizyme; In8Bio
 
Thriumaine Pillay
No Relationships to Disclose
 
Mariska ter Haak
Employment - Axogen; IN8bio
Consulting or Advisory Role - Axogen; IN8Bio
 
Samantha Youngblood
Employment - In8Bio
Stock and Other Ownership Interests - In8Bio
 
Louis Vaickus
No Relationships to Disclose
 
Mina Lobbous
No Relationships to Disclose